The paraventricular thalamus (PVT) is a central node in the integration of stress- and reward-related information that may serve as a pivotal site for opioid receptors to exert their effects. Kappa opioid receptors (KOPrs) and mu opioid receptors (MOPrs) have dissociable and opposing roles in circuits of stress and reward. Interestingly, both are highly expressed in the PVT, however it is not known how aversive KOPr and rewarding MOPr signalling converges to dictate PVT activity and, by proxy, whole brain effects. We have investigated the function of KOPrs and MOPrs in single PVT neurons using whole-cell voltage-clamp recordings in brain slices from female and male mice (4-8 weeks). The majority of PVT neurons (69%) co-expressed KOPr and MOPr. Activation of either receptor produced outward K currents, with no age and sex differences. In neurons co-expressing both opioid receptors, the MOPr-induced K current reversed around the theoretical equilibrium potential, whilst the KOPr current did not reverse at any holding potential tested. Furthermore, investigation of apparent inward currents produced by MOPr inverse agonists suggested the presence of tonically active MOPrs, predominantly in the anterior PVT. Activation of both KOPrs and MOPrs decreased glutamatergic input to PVT neurons by around 40%, whereas only KOPr activation decreased GABAergic input, by 46%. Together these data suggest that the balance of activation of KOPrs and MOPrs in the PVT plays a critical role in integrating stress- and reward-related signals.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.neuropharm.2025.110407 | DOI Listing |
Neuropharmacology
March 2025
Department of Life Sciences, University of Bath, Bath, BA2 7AY, United Kingdom. Electronic address:
The paraventricular thalamus (PVT) is a central node in the integration of stress- and reward-related information that may serve as a pivotal site for opioid receptors to exert their effects. Kappa opioid receptors (KOPrs) and mu opioid receptors (MOPrs) have dissociable and opposing roles in circuits of stress and reward. Interestingly, both are highly expressed in the PVT, however it is not known how aversive KOPr and rewarding MOPr signalling converges to dictate PVT activity and, by proxy, whole brain effects.
View Article and Find Full Text PDFCurr Drug Saf
March 2025
Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab 142001, India.
This editorial discusses opioid tolerance, a growing challenge in managing pain in chronic patients. With time, overuse of opioids causes less sensitivity and responsiveness of opioid receptors and leads to higher doses of opioids for the same level of pain management. Due to this, it increases the risk of side effects, such as opioid addiction, respiratory issues, and overdose.
View Article and Find Full Text PDFPharmacol Res
March 2025
Department of Psychological and Brain Sciences, Indiana University Bloomington, Bloomington, IN, 47405 United States; Program in Neuroscience, Indiana University Bloomington, Bloomington, IN, 47405 United States; Gill Institute for Neuroscience, Indiana University, Bloomington, IN, 47405 United States. Electronic address:
Recreational use of synthetic cannabinoid agonists (i.e., "spice compounds") that target the cannabinoid type 1 receptor (CB) can cause acute respiratory failure in humans.
View Article and Find Full Text PDFInvest Ophthalmol Vis Sci
March 2025
Department of Neuroscience and Experimental Therapeutics, Penn State University College of Medicine, Hershey, Pennsylvania, United States.
Purpose: To determine pathways in the trigeminal ganglion and corneal epithelium that are targeted by topical naltrexone (NTX) treatment for dry eye.
Methods: NTX drops were administered topically daily for 15 days to the corneal surface of male and female adult type 1 diabetic rats. Schirmer scores and corneal sensitivity were measured at baseline, 5, 10, and 15 days.
JACC Case Rep
March 2025
Atrium Health's Carolinas Medical Center, Department of Emergency Medicine, Division of Medical Toxicology, Charlotte, North Carolina, USA. Electronic address:
Kratom is derived from Mitragyna speciosa and contains active alkaloids that bind opioid, alpha-2 adrenergic, and 5-HT2A receptors. In vitro studies show kratom can inhibit myocardial potassium channels. We present a patient who developed a reversible Brugada pattern and QT prolongation after self-treating his attention-deficit/hyperactivity disorder with kratom.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!